Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Vaccitech

    NASDAQ: VACC · Real-Time Price · USD
    5.00
    0.51 (11.36%)
    At close: Nov 06, 2023, 10:00 PM

    Vaccitech Statistics

    Share Statistics

    Vaccitech has 38.55M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 38.55M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 n/a

    Shares Floating

    n/a
    		 28.3M

    Failed to Deliver (FTD) Shares

    n/a
    		 6,675

    FTD / Avg. Volume

    n/a
    		 0.91%

    Short Selling Information

    The latest short interest is 120.86K, so 0% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 120.86K

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 0.34%

    Short Ratio (days to cover)

    n/a
    		 2.49

    Valuation Ratios

    The PE ratio is -2.03 and the forward PE ratio is null. Vaccitech's PEG ratio is 0.

    PE Ratio

    n/a
    		 -2.03

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 8.28

    Forward PS

    n/a
    		 241.3

    PB Ratio

    n/a
    		 0.95

    P/FCF Ratio

    n/a
    		 -4.15

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Vaccitech.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 8.03, with a Debt / Equity ratio of 0.09.

    Current Ratio

    n/a
    		 8.03

    Quick Ratio

    n/a
    		 8.03

    Debt / Equity

    n/a
    		 0.09

    Debt / EBITDA

    n/a
    		 10.21

    Debt / FCF

    n/a
    		 -0.4

    Interest Coverage

    n/a
    		 -22.19

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $453,606.06

    Profits Per Employee

    n/a
    		 $-1,850,727.27

    Employee Count

    n/a
    		 33

    Asset Turnover

    n/a
    		 0.09

    Inventory Turnover

    n/a
    		 n/a

    Taxes

    Income Tax

    n/a
    		 -153K

    Effective Tax Rate

    n/a
    		 0.25%

    Stock Price Statistics

    The stock price has increased by 58.73% in the last 52 weeks. The beta is -0.27, so Vaccitech's price volatility has been lower than the market average.

    Beta

    n/a
    		 -0.27

    52-Week Price Change

    n/a
    		 58.73%

    50-Day Moving Average

    n/a
    		 3.35

    200-Day Moving Average

    n/a
    		 2.6

    Relative Strength Index (RSI)

    n/a
    		 49.91

    Average Volume (20 Days)

    n/a
    		 731,881

    Income Statement

    In the last 12 months, Vaccitech had revenue of 14.97M and earned -61.07M in profits. Earnings per share was -1.55.

    Revenue

    n/a
    		 14.97M

    Gross Profit

    n/a
    		 n/a

    Operating Income

    n/a
    		 1.18M

    Net Income

    n/a
    		 -61.07M

    EBITDA

    n/a
    		 1.18M

    EBIT

    n/a
    		 n/a

    Earnings Per Share (EPS)

    n/a
    		 -1.55
    Full Income Statement

    Balance Sheet

    The company has 110.66M in cash and 12.01M in debt, giving a net cash position of 98.66M.

    Cash & Cash Equivalents

    n/a
    		 110.66M

    Total Debt

    n/a
    		 12.01M

    Net Cash

    n/a
    		 98.66M

    Retained Earnings

    n/a
    		 -237.66M

    Total Assets

    n/a
    		 142M

    Working Capital

    n/a
    		 97.91M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -28.94M and capital expenditures -892K, giving a free cash flow of -29.83M.

    Operating Cash Flow

    n/a
    		 -28.94M

    Capital Expenditures

    n/a
    		 -892K

    Free Cash Flow

    n/a
    		 -29.83M

    FCF Per Share

    n/a
    		 -0.76
    Full Cash Flow Statement

    Margins

    Gross Margin

    n/a
    		 n/a

    Operating Margin

    n/a
    		 7.86%

    Pretax Margin

    n/a
    		 -409.03%

    Profit Margin

    n/a
    		 -408%

    EBITDA Margin

    n/a
    		 7.86%

    EBIT Margin

    n/a
    		 7.86%

    FCF Margin

    n/a
    		 -199.29%

    Dividends & Yields

    VACC does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for VACC.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 2.83

    Piotroski F-Score

    n/a
    		 3

    Add to Watchlist